Home › Funds › Brandes Global Equity Fund
Fund family: Datum One Series Trust · Filed by Datum One Series Trust (CIK 1806095) · SEC series S000084887
Share classes and tickers: BGEAX (C000249532), BGVCX (C000249533), BGVIX (C000249534), BGVRX (C000249531)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,080 with, 35 against, 0 abstentions (not counted as with management); 18 items carried no recommendation. Shareholder proposals: 10 FOR, 25 AGAINST, 0 abstained, by the filing’s own vote-source field.
Each ballot item this fund voted is set against the votes of the other Datum One Series Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Datum One Series Trust funds on all 40 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 593 | 0 |
| Corporate Governance | 157 | 9 |
| Capital Structure | 134 | 1 |
| Compensation | 113 | 0 |
| Audit-related | 72 | 0 |
| Say-on-Pay | 31 | 0 |
| Other Social Issues | 13 | 8 |
| Shareholder Rights and Defenses | 10 | 8 |
| Environment or Climate | 5 | 5 |
| Extraordinary Transactions | 2 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Micron Technology, Inc. | January 15, 2026 | $3M | 12 | 1 |
| The Cigna Group | April 22, 2026 | $2M | 15 | 1 |
| Merck & Co., Inc. | May 26, 2026 | $2M | 18 | 3 |
| Citigroup Inc. | May 20, 2026 | $2M | 16 | 0 |
| Textron Inc. | April 29, 2026 | $2M | 13 | 0 |
| UnitedHealth Group Incorporated | June 1, 2026 | $2M | 12 | 1 |
| Becton, Dickinson and Company | January 27, 2026 | $2M | 16 | 0 |
| Pfizer Inc. | April 23, 2026 | $2M | 16 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| January 15, 2026 | Micron Technology, Inc. | Shareholder Proposal Requesting Amendment To Shareholder Special Meeting Right. Shareholder proposal | For | Against |
| April 22, 2026 | The Cigna Group | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposal | For | Against |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | For | Against |
| April 23, 2026 | Pfizer Inc. | Adopt an Independent Chair Policy Shareholder proposal | For | Against |
| May 21, 2026 | EPAM Systems, Inc. | To hold an advisory vote on a stockholder proposal, entitled ""Give Shareholders an Ability to Call for a Special Shareholder Meeting."" Shareholder proposal | For | Against |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting independent board chair Shareholder proposal | Against | For |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposal | Against | For |
| April 28, 2026 | Wells Fargo & Company | Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Shareholder proposal | Against | For |
| April 28, 2026 | Wells Fargo & Company | Shareholder Proposal - Govern by Majority Vote. Shareholder proposal | Against | For |
| June 10, 2026 | Comcast Corporation | Adopt policy to have an independent chair Shareholder proposal | For | Against |
1,134 ballot items at 71 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Brandes Global Equity Fund (BGEAX) voted at 71 shareholder meetings of 67 companies, on 1,134 ballot items in all. Where management made a recommendation, the fund followed it on 96.9% of the items and voted against it 35 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted on 35 shareholder proposals. It voted the same way as most Datum One Series Trust funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.